Heart Disease Trial, Recruiting (NCT06161402)

Heart Disease Trial, Recruiting NCT06161402 Sponsor: The University of Hong Kong Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06161402 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 50 or older
People who have had a confirmed diagnosis of heart failure recorded in their medical records for at least 6 months
People whose grip strength is below a certain level (under 28kg for men, under 18kg for women), who score 9 or below on a physical function test called the Short Physical Performance Battery, and who have lower-than-normal muscle mass as measured by a body composition scan — all three conditions together meet a recognised definition of sarcopenia (muscle loss)
People whose heart failure is currently stable and who do not have any sudden or active breathing or muscle/joint problems that would prevent them from doing exercise
People who have not been doing regular resistance or strength training in the past 6 months

Who may not be able to join:

No formal exclusion criteria have been listed for this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Doris Sau Fung YU, PhD, The University of Hong Kong

Phone: 852 3817 6319

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06161402

Sponsor: The University of Hong Kong

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: 852 3817 6319

More information: https://clinicaltrials.gov/study/NCT06161402

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 50 or older
People who have had a confirmed diagnosis of heart failure recorded in their medical records for at least 6 months
People whose grip strength is below a certain level (under 28kg for men, under 18kg for women), who score 9 or below on a physical function test called the Short Physical Performance Battery, and who have lower-than-normal muscle mass as measured by a body composition scan — all three conditions together meet a recognised definition of sarcopenia (muscle loss)
People whose heart failure is currently stable and who do not have any sudden or active breathing or muscle/joint problems that would prevent them from doing exercise
People who have not been doing regular resistance or strength training in the past 6 months

Who may not be able to join:

No formal exclusion criteria have been listed for this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The University of Hong Kong

Registry

ClinicalTrials.gov

Start date

1 December 2023

Est. completion

31 December 2025

Where this trial is recruiting

Hong Kong

Primary endpoints

Appendicular skeletal muscular index (ASMI); Handgrip strength; Physical function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov